Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Mol Cancer Ther. 2019 Sep 23;19(1):231–246. doi: 10.1158/1535-7163.MCT-19-0508

Figure 4. Stat5 promotes viability of prostate cancer cells during ENZ treatment.

Figure 4.

Constitutively active (CA) Stat5 or GFP were lentivirally expressed in CWR22Pc and LAPC-4 cells for 2 days followed by ENZ treatment (5, 10, 20, 30 and 40 μM) or vehicle for 6 days (A and D). The fractions of viable cells were determined by counting three separate fields from each of the three parallel wells, and the averages are indicated by a line graph with SDs. Crystal violet staining and (B and E) immunoblotting of whole cell lysates (WCL) for Stat5 and Actin on day 6 (C and F).